From: Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions
AE
All grades (n = 78)
Grade 3/4 (n = 39)
Child-Pugh A
Child-Pugh B
P
HFSR
23
10
4
0.340
Diarrhea
19
6
0.655
Nausea
7
1
0
0.475
Anorexia
0.510
Fatigue
8
2
0.991
Rash/desquamation
15
3
0.383